Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,212,861 |
|
|||||
| News | - | ||||||
| Day High | 1.51 | Low High |
|||||
| Day Low | 1.41 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Atossa Therapeutics Inc | ATOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 5.63% | 1.50 | 18:54:45 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.41 | 1.41 | 1.51 | 1.49 | 1.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,395 | 1,212,861 | $ 1.48 | $ 1,794,618 | - | 0.5901 - 2.31 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:55:20 | 20 | $ 1.51 | USD |
Atossa Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 185.45M | 125.30M | - | 0 | -30.09M | -0.24 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Atossa Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.6509 | 1.66 | 1.24 | 1.40 | 2,052,056 | -0.1509 | -9.14% |
| 1 Month | 1.92 | 2.31 | 1.24 | 1.78 | 2,940,413 | -0.42 | -21.88% |
| 3 Months | 0.8602 | 2.31 | 0.8279 | 1.59 | 1,712,248 | 0.6398 | 74.38% |
| 6 Months | 0.6511 | 2.31 | 0.62 | 1.43 | 996,497 | 0.8489 | 130.38% |
| 1 Year | 0.6938 | 2.31 | 0.5901 | 1.25 | 842,453 | 0.8062 | 116.20% |
| 3 Years | 1.77 | 9.80 | 0.50 | 3.76 | 3,333,381 | -0.27 | -15.25% |
| 5 Years | 3.03 | 9.80 | 0.50 | 3.18 | 3,509,062 | -1.53 | -50.50% |
Atossa Therapeutics Description
| Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use. |
